Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT201102223051N3Phase 3Completed
Phase 3 trial of melatonin in anxiety disorder (2 arms), sponsored by Qazvin University of Medical Sciences. Primary endpoints: Anxiety score, Pain score and 2 more. Started Sep 2009; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT201102223051N3.